Amplicore Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
Amplicore General Information
Description
Developer of injectable therapeutic drugs designed to treat degenerative musculoskeletal disorders to serve unmet medical needs. The company's drugs promote cartilage regeneration and suppress enzymatic activities to treat degenerative musculoskeletal disorders, enabling healthcare organizations to seamlessly provide relief to patients from joint pain.
Contact Information
Website
www.amplicorepharma.comCorporate Office
- 5412 Courseview Drive
- Suite 125
- Mason, OH 45204
- United States
Corporate Office
- 5412 Courseview Drive
- Suite 125
- Mason, OH 45204
- United States
Amplicore Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | 20-Oct-2025 | Completed | Clinical Trials - Phase 2 | |||
| 8. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 7. Early Stage VC (Series A) | 21-Apr-2022 | Completed | Clinical Trials - Phase 2 | |||
| 6. Early Stage VC | 19-Mar-2021 | Cancelled | Clinical Trials - Phase 2 | |||
| 5. Seed Round | 01-Mar-2021 | Completed | Clinical Trials - Phase 2 | |||
| 4. Seed Round | 07-Jan-2020 | Completed | Startup | |||
| 3. Grant | 01-Jan-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | $180K | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2018 | $180K | $180K | Completed | Startup |
Amplicore Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 1 | ||||||||
| Seed 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Amplicore Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amplicore Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amplicore Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plug and Play | Accelerator/Incubator | Minority | ||
| Pandect / Berkeley Catalyst Fund | Venture Capital | Minority | ||
| Photon Fund | Venture Capital | Minority | ||
| United States Department of War | Government | |||
| Ohio Department of Development | Government | Minority |
Amplicore FAQs
-
When was Amplicore founded?
Amplicore was founded in 2018.
-
Where is Amplicore headquartered?
Amplicore is headquartered in Mason, OH.
-
What is the size of Amplicore?
Amplicore has 7 total employees.
-
What industry is Amplicore in?
Amplicore’s primary industry is Drug Discovery.
-
Is Amplicore a private or public company?
Amplicore is a Private company.
-
What is Amplicore’s current revenue?
The current revenue for Amplicore is .
-
How much funding has Amplicore raised over time?
Amplicore has raised $37M.
-
Who are Amplicore’s investors?
Plug and Play, Pandect / Berkeley Catalyst Fund, Photon Fund, United States Department of War, and Ohio Department of Development are 5 of 6 investors who have invested in Amplicore.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
